Lightnews — Scholar-powered news

Reposted by Hannes Hagström

Otto English @ottoenglish.bsky.social · 12d

Nathan Gill is no fringe politician.

He was the leader of the Reform Party and before that UKIP in Wales.

A Brexit Party MEP.

A friend and ally of Nigel Farage, who in 2016 called him:

"terrific," and "as honest as the day is long."

This is a MASSIVE story

www.bbc.co.uk/news/article...

Reform UK's ex-Wales leader Nathan Gill admits pro-Russia bribery

Nathan Gill admits eight charges of bribery while being a Member of the European Parliament.

www.bbc.co.uk

180 2K 3.5K

Reposted by Hannes Hagström

Dr Ellie Murray, ScD @epiellie.bsky.social · Jul 12

A man in Arizona just died from pneumonic plague.

Before you freak out, here are 5 things you need to know about plague.

LInk: open.substack.com/pub/epiellie...

Plague Death in Arizona: 5 Things you Need to Know

Yesterday, Coconino County, Arizona reported the death of a man from pneumonic plague.

open.substack.com

3 32 76

Reposted by Hannes Hagström

Journal of Internal Medicine @jinternmed.bsky.social · Jul 4

Welcome to read the Editor´s Choice in July!

➡️Accumulating understanding that diet, stress, toxins, and infections affect offspring health.

🔗 doi.org/10.1111/joim.20094
👉Also, read the July issue: onlinelibrary.wiley.com/toc/13652796/2025/298/1

#epigenetics #inflammatorymemory

1 2

Reposted by Hannes Hagström

Journal of Internal Medicine @jinternmed.bsky.social · Jul 4

New Review Article to read! Gaucher disease, state of the art and perspectives #gaucherdisease #glucocerebrosidase #lysosomes

🔗Read here: doi.org/10.1111/joim...

1 1

Reposted by Hannes Hagström

Journal of Internal Medicine @jinternmed.bsky.social · Jul 2

New Editorial! Community prevalence of advanced liver fibrosis in Type 2 diabetes—How big is the challenge? #MASLD #T2D

🔗 doi.org/10.1111/joim...
👉This Editorial comments on: doi.org/10.1111/joim...

<em>Journal of Internal Medicine</em> | Wiley Online Library

Click on the article title to read more.

doi.org

1 2

Reposted by Hannes Hagström

Journal of Internal Medicine @jinternmed.bsky.social · Jun 18

Read the News Release! Fatty liver – but not liver damage – common in type 2 diabetes | EurekAlert! www.eurekalert.org/news-release...

Fatty liver – but not liver damage – common in type 2 diabetes

Six out of ten people with type 2 diabetes had fatty liver in a new study from Linköping University in Sweden. Of these, only a small percentage had developed more severe liver disease. The study...

www.eurekalert.org

2 3

Hannes Hagström @liverepi.bsky.social · Jun 6

New review from us: Clinical Utility of Non-Invasive Tests for Liver Fibrosis in People Living With Alpha-1 Antitrypsin Deficiency. Happy to coauthor with leading experts and led by Joost Boeckmans. Nice start of a new project on AATD using Swedish data.

onlinelibrary.wiley.com/doi/10.1111/...

Clinical Utility of Non‐Invasive Tests for Liver Fibrosis in People Living With Alpha‐1 Antitrypsin Deficiency

Severe alpha-1 antitrypsin deficiency (AATD) is a rare genetic condition characterised by low systemic levels of alpha-1 antitrypsin due to its retention in the liver. Consequently, it predisposes in...

onlinelibrary.wiley.com

Reposted by Hannes Hagström

Doctors Without Borders / Médecins Sans Frontières (MSF) @msf.ca · Jun 5

Our medical staff are donating their own blood to provide life-saving treatment for patients in #Gaza.

Patients that were gunned down while trying to get food.

Food for their families.

Food to live.

We need an immediate #ceasefire, now.

2 190 290

Reposted by Hannes Hagström

Journal of Internal Medicine @jinternmed.bsky.social · May 20

Continuing today! The 19th Key symposium 2025: Planetary Health – connect the dots. What saves the planet saves our health!

19-21 May in Stockholm, Sweden.

Gunhild Stordalen opens today´s program: key-symposium2025.se

#PlanetaryHealth25

1 2

Hannes Hagström @liverepi.bsky.social · May 2

Pretty cool study

pubmed.ncbi.nlm.nih.gov/40309768/

Weight loss in MASLD restores the balance of liver fatty acid sources - PubMed

BACKGROUNDLipogenesis contributes substantially to the pathological accumulation of intrahepatic triacylglycerol (IHTG) in metabolic dysfunction-associated steatotic liver disease (MASLD). Since hepat...

pubmed.ncbi.nlm.nih.gov

1

Reposted by Hannes Hagström

Journal of Internal Medicine @jinternmed.bsky.social · Apr 28

The May issue is now online!

👉Read our latest articles!

🔗 onlinelibrary.wiley.com/toc/13652796/2025/297/5

#medtwitter #cardiovascular #SGLT2 #diabetes #osteoporosis #Addisson #kidneycancer #hypertension #CKD

1 2

Reposted by Hannes Hagström

Matthias Löhr ʚїɞ @maloehr.bsky.social · Apr 24

The #JSGE @myueg.bsky.social symposium with #lenakristinconradi and @liverepi.bsky.social on using a metabolic switch in #pancreaticcancer for therapy and #MASLD respectively. Truly worth their #risingstar awards!

2 2

Hannes Hagström @liverepi.bsky.social · Apr 13

Tl;dr: Many patients with diagnosed or presumed MASLD will have elevated PEth, suggestive of MetALD/ALD. And, PEth is predictive of liver outcomes. Big thanks to the super talented Juan Vaz for leading this!

⁉️If you are interested in this unique cohort and what can be done, get in touch.

4

Hannes Hagström @liverepi.bsky.social · Apr 13

🚨New paper from us in Journal of Hepatology - Using PEth values on >50,000 persons to predict outcomes. www.sciencedirect.com/science/arti...

Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes

Phosphatidylethanol (PEth) is an ethanol metabolite used as a specific biomarker for recent alcohol consumption. We aimed to determine the proportion …

www.sciencedirect.com

1 3 11

Reposted by Hannes Hagström

Rob Brierley @robbrierley.bsky.social · Apr 9

FDA approves first therapy for IgG4-related disease

www.medscape.com/viewarticle/...

#GastroSky #MedSky #RheumSky

FDA Approves First and Only Therapy for IgG4-RD

The CD19+ B-Cell targeted therapy reduced flare risk by 87% in a phase 3 clinical trial.

www.medscape.com

1 6

Reposted by Hannes Hagström

Elin Bjarnegård @elinbja.bsky.social · Apr 8

Are you a researcher active outside of Europe who might consider coming to Sweden? Check out this @vetenskapsradet.bsky.social grant for recruitment of international visiting researchers!
www.vr.se/english/appl...

Grant for recruiting international visiting researchers to Sweden

The purpose of the grant is to provide higher education institutions and other research organisations the opportunity to develop and strengthen a research field by recruiting a distinguished researche...

www.vr.se

6 8

Hannes Hagström @liverepi.bsky.social · Apr 8

Vote for Peter Stenvinkel as a "Sommar" radio show host: www.sverigesradio.se/artikel/kand...

Would be such a nice experience!

7. Den smarta naturen – Peter Stenvinkel - Sommar & Vinter i P1

Utmaningarna vår värld står inför tycks oändliga. Men tänk om det inte är så? I detta Sommarprat får vi lära oss hur vi med hjälp av forskning, naturens ...

www.sverigesradio.se

Hannes Hagström @liverepi.bsky.social · Mar 26

New from Juan Vaz in our group: www.sciencedirect.com/science/arti...

In >5400 patients with primary liver cancer (HCC), those with lower socio-economic parameters such as income levels have more advanced tumors at diagnosis, less frequently receive curative treatments and have poorer prognosis.

Socioeconomic inequalities in diagnostics, care and survival outcomes for hepatocellular carcinoma in Sweden: a nationwide cohort study

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. This study evaluates how strongly socioeconomic factors assoc…

www.sciencedirect.com

1 2

Hannes Hagström @liverepi.bsky.social · Mar 24

New paper from us in @jhepatology.bsky.social: www.journal-of-hepatology.eu/article/S016...
Causes of death in >13,000 persons with #MASLD - check it out #liversky. So proud of co-senior author Axel Wester and first author medical student Gabriel Issa for the work!

Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden

Data on cause-specific mortality in metabolic dysfunction-associated steatotic liver disease (MASLD) are limited. We aimed to determine the rate and risk of death from different causes in patients wit...

www.journal-of-hepatology.eu

1 6 17

Hannes Hagström @liverepi.bsky.social · Mar 24

Love it!

Hannes Hagström @liverepi.bsky.social · Mar 21

Interesting study from Alina Allen's group: pubmed.ncbi.nlm.nih.gov/40105977/

Reassuring that MASLD diagnosis identified through screening led to weight loss and no major issues with increased anxiety.

Population perspectives on benefits and harms of screening for metabolic dysfunction-associated steatotic liver disease - PubMed

Screening for diseases can have psychological impacts, such as anxiety, and requires acceptability from the population to be effective. This study examined the perspectives on the benefits and harms o...

pubmed.ncbi.nlm.nih.gov

1 3

Hannes Hagström @liverepi.bsky.social · Mar 18

No issues here!
Good luck to all applicants…. 🙏🏻

1 2

Hannes Hagström @liverepi.bsky.social · Mar 18

April number of @jinternmed.bsky.social now out: onlinelibrary.wiley.com/toc/13652796...

<em>Journal of Internal Medicine</em> | Wiley Online Library

Click on the title to browse this issue

onlinelibrary.wiley.com

1

Reposted by Hannes Hagström

EASL @easlnews.bsky.social · Mar 17

Have you secured your spot for #EASLCongress 2025 on 7-10 May?

🌍Join us in Amsterdam or online to transform liver care worldwide! easlcongress.eu/2025-registr...
📜The deadline to submit your late-breaker abstract is TODAY, 17 March! easlcongress.eu/2025-abstrac...

2 5